REGISTERED NUMBER: |
UNAUDITED FINANCIAL STATEMENTS |
FOR THE YEAR ENDED 31 DECEMBER 2023 |
FOR |
GLAN YR AFON SURGERY LTD |
REGISTERED NUMBER: |
UNAUDITED FINANCIAL STATEMENTS |
FOR THE YEAR ENDED 31 DECEMBER 2023 |
FOR |
GLAN YR AFON SURGERY LTD |
GLAN YR AFON SURGERY LTD (REGISTERED NUMBER: 07700937) |
CONTENTS OF THE FINANCIAL STATEMENTS |
FOR THE YEAR ENDED 31 DECEMBER 2023 |
Page |
Company information | 1 |
Balance sheet | 2 |
Notes to the financial statements | 3 |
GLAN YR AFON SURGERY LTD |
COMPANY INFORMATION |
FOR THE YEAR ENDED 31 DECEMBER 2023 |
DIRECTORS: |
REGISTERED OFFICE: |
REGISTERED NUMBER: |
ACCOUNTANTS: |
Limited liability partnership in England & Wales |
Registered number OC312313 |
Elfed House |
Oak Tree Court |
Cardiff Gate Business Park |
Cardiff |
CF23 8RS |
GLAN YR AFON SURGERY LTD (REGISTERED NUMBER: 07700937) |
BALANCE SHEET |
31 DECEMBER 2023 |
2023 | 2022 |
Notes | £ | £ |
FIXED ASSETS |
Tangible assets | 4 |
CURRENT ASSETS |
Debtors | 5 |
Cash at bank |
CREDITORS |
Amounts falling due within one year | 6 | ( |
) | ( |
) |
NET CURRENT ASSETS |
TOTAL ASSETS LESS CURRENT LIABILITIES |
PROVISIONS FOR LIABILITIES | ( |
) | ( |
) |
NET ASSETS |
CAPITAL AND RESERVES |
Called up share capital | 7 |
Retained earnings |
SHAREHOLDERS' FUNDS |
The directors acknowledge their responsibilities for: |
(a) | ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and |
(b) | preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company. |
In accordance with Section 444 of the Companies Act 2006, the Income statement has not been delivered. |
The financial statements were approved and authorised for issue by the Board of Directors and authorised for issue on |
GLAN YR AFON SURGERY LTD (REGISTERED NUMBER: 07700937) |
NOTES TO THE FINANCIAL STATEMENTS |
FOR THE YEAR ENDED 31 DECEMBER 2023 |
1. | STATUTORY INFORMATION |
Glan yr Afon Surgery Ltd is a |
The presentation currency of the financial statements is Pound Sterling (£). |
2. | ACCOUNTING POLICIES |
BASIS OF PREPARING THE FINANCIAL STATEMENTS |
The financial statements have been prepared on a going concern basis, which assumes the continuing support of the company's directors, bankers and other creditors. The directors believe that this support will continue and are satisfied that the company is a going concern. |
TURNOVER |
Turnover represents amounts receivable for services provided. |
TANGIBLE FIXED ASSETS |
Plant and machinery etc | - |
Tangible fixed assets are initially measured at cost. After initial recognition, tangible fixed assets are measured at cost less any accumulated depreciation and any accumulated impairment losses. |
FINANCIAL INSTRUMENTS |
Financial instruments are initially measured at fair value on the date on which it is entered into and are subsequently measured at fair value through profit or loss. |
TAXATION |
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. |
Current or deferred taxation assets and liabilities are not discounted. |
Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date. |
DEFERRED TAX |
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date. |
Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference. |
Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. |
GLAN YR AFON SURGERY LTD (REGISTERED NUMBER: 07700937) |
NOTES TO THE FINANCIAL STATEMENTS - continued |
FOR THE YEAR ENDED 31 DECEMBER 2023 |
2. | ACCOUNTING POLICIES - continued |
PENSION COSTS AND OTHER POST-RETIREMENT BENEFITS |
An NHS superannuation pension scheme is operated. Superannuation contributions payable to the scheme are charged to the profit and loss in the period to which they relate. |
3. | EMPLOYEES AND DIRECTORS |
The average number of employees during the year was |
4. | TANGIBLE FIXED ASSETS |
Plant and |
machinery |
etc |
£ |
COST |
At 1 January 2023 |
Additions |
At 31 December 2023 |
DEPRECIATION |
At 1 January 2023 |
Charge for year |
At 31 December 2023 |
NET BOOK VALUE |
At 31 December 2023 |
At 31 December 2022 |
5. | DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |
2023 | 2022 |
£ | £ |
Trade debtors |
Other debtors |
6. | CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |
2023 | 2022 |
£ | £ |
Trade creditors |
Taxation and social security |
GLAN YR AFON SURGERY LTD (REGISTERED NUMBER: 07700937) |
NOTES TO THE FINANCIAL STATEMENTS - continued |
FOR THE YEAR ENDED 31 DECEMBER 2023 |
7. | CALLED UP SHARE CAPITAL |
Allotted, issued and fully paid: |
Number: | Class: | Nominal | 2023 | 2022 |
value: | £ | £ |
ordinary A shares | 1 | 50 | 50 |
ordinary D shares | 1 | 50 | 50 |
ordinary E shares | 1 | 25 | 25 |
125 | 125 |
8. | DIRECTORS' ADVANCES, CREDITS AND GUARANTEES |
During the year, the following material transactions with Directors took place: |
Dr K G Syal |
£ |
Due to director at 1 January 2023 | - |
Drawn from the company during the year to 31 December 2023 | (218,311 | ) |
Repaid to the company during the year to 31 December 2023 | 7,542 |
Dividends declared | 210,769 |
Due to director at 31 December 2023 | - |
Dr G Mathews |
£ |
Due to director at 1 January 2023 | - |
Drawn from the company during the year to 31 December 2023 | (192,699 | ) |
Repaid to the company during the year to 31 December 2023 | 10,388 |
Dividends declared | 182,311 |
Due to director at 31 December 2023 | - |
Dr A Samarasinghe |
£ |
Due to director at 1 January 2023 | - |
Drawn from the company during the year to 31 December 2023 | (97,339 | ) |
Dividends declared | 97,339 |
Due to director at 31 December 2023 | - |